Differentially expressed microRNAs in plasma exosomes from patients with chronic hepatitis B or hepatitis B virus-related acute-on-chronic liver failure: A bioinformatics analysis

Shuyang ZHANG; Yanzhen BI; Shousheng LIU; Sheng LIU; Yongning XIN

doi:10.3969/j.issn.1001-5256.2023.08.013

Volume 39 Issue 8

Aug. 2023

Turn off MathJax

Article Contents

Abstract

References

Supplements

Article Navigation > Journal of Clinical Hepatology > 2023 > 39(8): 1848-1856

PDF( 5016 KB)

Differentially expressed microRNAs in plasma exosomes from patients with chronic hepatitis B or hepatitis B virus-related acute-on-chronic liver failure: A bioinformatics analysis

DOI: 10.3969/j.issn.1001-5256.2023.08.013

Shuyang ZHANG^{1, 2},
Yanzhen BI²,
Shousheng LIU³,
Sheng LIU^{4
,
,
,},
Yongning XIN^{1
,
,
,}

1.
Qingdao Clinical Medical College of Nanjing Medical University, Qingdao, Shandong 266011, China
2.
Department of Infectious Diseases, Qingdao Municipal Hospital, Qingdao, Shandong 266011, China
3.
Clinical Research Center, Qingdao Municipal Hospital, Qingdao, Shandong 266071, China
4.
Department of Blood Purification, Qingdao Sixth People's Hospital, Qingdao, Shandong 266033, China

Research funding:

National Natural Science Foundation of China (82202416);

Special Fund for Artificial Liver of Beijing Public Welfare Foundation (RGGJJ-2021-030)

More Information

Corresponding author: LIU Sheng, lius123@163.com (ORCID: 0000-0002-9485-0211); XIN Yongning, xinyongning@163.com (ORCID: 0000-0002-3692-7655)
Received Date: 2022-12-07
Accepted Date: 2023-01-17
Published Date: 2023-08-20

Abstract

Abstract

Objective To investigate the differences in plasma exosomal microRNA (miRNA) expression profile between patients with chronic hepatitis B (CHB) and those with hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF), as well as their functions and biological processes, and to provide a reference for the clinical diagnosis of HBV-ACLF. Methods Six patients with CHB who were hospitalized in Department of Infectious Diseases, Qingdao Municipal Hospital, and six patients with HBV-ACLF who were treated in Blood Purification Center of Qingdao Sixth People's Hospital from October 2021 to June 2022 were enrolled. Illumina high-throughput sequencing was used to analyze the plasma exosomal miRNAs of these patients to obtain the differentially expressed miRNAs between the two groups. The differentially expressed miRNAs were screened, and a functional enrichment analysis was performed to identify the biological processes involving such miRNAs. The Mann-Whitney U rank sum test was used for comparison of continuous data between two groups, and the chi-square test was used for comparison of categorical data between groups. Results A total of 249 differentially expressed exosomal miRNAs were obtained according to the criteria of upregulation >2-fold or downregulation >2-fold, with P < 0.05, and compared with the CHB group, there were 126 upregulated miRNAs and 123 downregulated miRNAs. The bioinformatics analysis showed that these differentially expressed miRNAs were mainly involved in the biological processes such as gonadal development, regulation of protein stability, and cellular response to external stimuli, and they were closely associated with the signaling pathways such as hepatitis B, the role of proteoglycans in cancer, regulation of stem cell pluripotency, MAPK, Hippo, TNF, and lipid metabolism. Conclusion The differentially expressed miRNAs identified by Illumina high-throughput sequencing may be used as biomarkers for the early diagnosis and prognostic evaluation of HBV-ACLF.
- Hepatitis B, Chronic,
- Acute-On-Chronic Liver Failure,
- Exosomes,
- MicroRNAs

FullText(HTML)

References(26)

References

[1]	TANG Y, LIANG H, ZENG G, et al. Advances in new antivirals for chronic hepatitis B[J]. Chin Med J (Engl), 2022, 135(5): 571-583. DOI: 10.1097/CM9.0000000000001994.
[2]	ARROYO V, MOREAU R, JALAN R. Acute-on-chronic liver failure[J]. N Engl J Med, 2020, 382(22): 2137-2145. DOI: 10.1056/NEJMra1914900.
[3]	CONSOLE L, SCALISE M, INDIVERI C. Exosomes in inflammation and role as biomarkers[J]. Clin Chim Acta, 2019, 488: 165-171. DOI: 10.1016/j.cca.2018.11.009.
[4]	Chinese Society of Infectious Diseases, Chinese Medical Association; Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B(version 2019)[J]. J Clin Hepatol, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007. 中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007.
[5]	Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007. 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
[6]	GURUNATHAN S, KANG MH, JEYARAJ M, et al. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes[J]. Cells, 2019, 8(4): 307. DOI: 10.3390/cells8040307.
[7]	MORI MA, LUDWIG RG, GARCIA-MARTIN R, et al. Extracellular miRNAs: from biomarkers to mediators of physiology and disease[J]. Cell Metab, 2019, 30(4): 656-673. DOI: 10.1016/j.cmet.2019.07.011.
[8]	ZHANG J, LI S, LI L, et al. Exosome and exosomal microRNA: trafficking, sorting, and function[J]. Genomics Proteomics Bioinformatics, 2015, 13(1): 17-24. DOI: 10.1016/j.gpb.2015.02.001.
[9]	CHEN W, YAN ZH, WANG YM, et al. Genome-wide microarray-based analysis of miRNAs expression in patients with acute-on-chronic liver failure[J]. Hepatobiliary Pancreat Dis Int, 2014, 13(1): 32-39. DOI: 10.1016/s1499-3872(14)60004-7.
[10]	HU J, XU Y, HAO J, et al. MiR-122 in hepatic function and liver diseases[J]. Protein Cell, 2012, 3(5): 364-371. DOI: 10.1007/s13238-012-2036-3.
[11]	TANIMIZU N, KOBAYASHI S, ICHINOHE N, et al. Downregulation of miR122 by grainyhead-like 2 restricts the hepatocytic differentiation potential of adult liver progenitor cells[J]. Development, 2014, 141(23): 4448-4456. DOI: 10.1242/dev.113654.
[12]	TU WL, YOU LR, TSOU AP, et al. Pten haplodeficiency accelerates liver tumor growth in miR-122a-Null mice via expansion of periportal hepatocyte-like cells[J]. Am J Pathol, 2018, 188(11): 2688-2702. DOI: 10.1016/j.ajpath.2018.07.019.
[13]	KRAUSKOPF J, CAIMENT F, CLAESSEN SM, et al. Application of high-throughput sequencing to circulating microRNAs reveals novel biomarkers for drug-induced liver injury[J]. Toxicol Sci, 2015, 143(2): 268-276. DOI: 10.1093/toxsci/kfu232.
[14]	BAI S, NASSER MW, WANG B, et al. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib[J]. J Biol Chem, 2009, 284(46): 32015-32027. DOI: 10.1074/jbc.M109.016774.
[15]	JOPLING CL, YI M, LANCASTER AM, et al. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA[J]. Science, 2005, 309(5740): 1577-1581. DOI: 10.1126/science.1113329.
[16]	CHEN S, YANG L, PAN A, et al. Inhibitory effect on the hepatitis B cells through the regulation of miR-122-MAP3K2 signal pathway[J]. An Acad Bras Cienc, 2019, 91(2): e20180941. DOI: 10.1590/0001-3765201920180941.
[17]	WEN Y, PENG SF, FU L, et al. Serum levels of miRNA in patients with hepatitis B virus-associated acute-on-chronic liver failure[J]. Hepatobiliary Pancreat Dis Int, 2018, 17(2): 126-132. DOI: 10.1016/j.hbpd.2018.03.004.
[18]	WU L, NGUYEN LH, ZHOU K, et al. Precise let-7 expression levels balance organ regeneration against tumor suppression[J]. Elife, 2015, 4: e09431. DOI: 10.7554/eLife.09431.
[19]	MCDANIEL K, HUANG L, SATO K, et al. The let-7/Lin28 axis regulates activation of hepatic stellate cells in alcoholic liver injury[J]. J Biol Chem, 2017, 292(27): 11336-11347. DOI: 10.1074/jbc.M116.773291.
[20]	MATSUURA K, AIZAWA N, ENOMOTO H, et al. Circulating let-7 levels in serum correlate with the severity of hepatic fibrosis in chronic hepatitis C[J]. Open Forum Infect Dis, 2018, 5(11): ofy268. DOI: 10.1093/ofid/ofy268.
[21]	SANDHU GK, MCMILLIN M, FRAMPTON G, et al. Let-7f-dependent suppression of neuronal IGF1 by aberrant TGFβ1 signaling contributes to the neurological decline observed during acute liver failure[J]. J Gastroenterology, 2017, 152(5): S1066. DOI: 10.1016/s0016-5085(17)33601-6.
[22]	YANG S, CHEN Z, FAN D, et al. Retracted Article: MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3[J]. RSC Adv, 2018, 8(61): 34973-34983. DOI: 10.1039/c8ra07055e.
[23]	CHANDEL R, DAS A, CHAWLA YK, et al. Mo1477 Progression of hepatocellular carcinoma is associated with the up regulation of rno-miR-96/182/183 cluster in liver of wistar rats[J]. J Gastroenterology, 2016, 150(4): S1125. DOI: 10.1016/s0016-5085(16)33799-4
[24]	MANDAL R, HARDIN H, BAUS R, et al. Analysis of miR-96 and miR-133a expression in gastrointestinal neuroendocrine neoplasms[J]. Endocr Pathol, 2017, 28(4): 345-350. DOI: 10.1007/s12022-017-9504-5.
[25]	SHI Y, JIA M, XU L, et al. miR-96 and autophagy are involved in the beneficial effect of grape seed proanthocyanidins against high-fat-diet-induced dyslipidemia in mice[J]. Phytother Res, 2019, 33(4): 1222-1232. DOI: 10.1002/ptr.6318.
[26]	BAJAJ JS, REDDY KR, O'LEARY JG, et al. Serum levels of metabolites produced by intestinal microbes and lipid moieties independently associated with acute-on-chronic liver failure and death in patients with cirrhosis[J]. Gastroenterology, 2020, 159(5): 1715-1730. e12. DOI: 10.1053/j.gastro.2020.07.019.

Relative Articles

[1]	Hua TONG, Yue LUO, Yadong WANG. Regulatory mechanism of exosomes in liver failure and the application value in diagnosis and treatment[J]. Journal of Clinical Hepatology, 2024, 40(9): 1897-1901. doi: 10.12449/JCH240928
[2]	Fang WANG, Jianhua LU, Yonggang LIU, Xinyu ZHANG, Huimin YAN. Expression and significance of immune cells in patients with hepatitis B virus-related acute-on-chronic pre-liver failure[J]. Journal of Clinical Hepatology, 2023, 39(1): 77-82. doi: 10.3969/j.issn.1001-5256.2023.01.012
[3]	Yuanpeng MAO, Zhe YU, Aqian SONG, Hongshan WEI. From viral hepatitis to hepatocellular carcinoma: The role of exosomal microRNAs[J]. Journal of Clinical Hepatology, 2023, 39(2): 439-443. doi: 10.3969/j.issn.1001-5256.2023.02.030
[4]	Ziwei GUO, Hening CHEN, Xu CAO, Jiaxin ZHANG, Ningyi ZHANG, Qian JIN, Xiaoke LI, Yongan YE. Mechanism of action of exosomes in the development and progression of hepatitis B virus-related chronic hepatitis and hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2022, 38(9): 2125-2129. doi: 10.3969/j.issn.1001-5256.2022.09.034
[5]	Luxiang HAN, Huixin TANG, Zhenfeng ZHAO, Shanshan LI, Quanyi WANG, Lingbin KONG, Huiying BI, Zhenfeng SHU, Zhongping DUAN, Yu CHEN, feng HONG. Effect of exosomes from adult human liver-derived stem cells on concanavalin A-induced acute liver injury in mice[J]. Journal of Clinical Hepatology, 2022, 38(5): 1101-1105. doi: 10.3969/j.issn.1001-5256.2022.05.024
[6]	Hong XIANG, Fenglin HU, Xufeng TAO, Xin QI, Jinnan ZHANG, Dong SHANG. Artemisia capillaris Thunb. decoction exerts a protective effect on rats with severe acute pancreatitis by regulating the lncRNA PVT1/miRNA-30a-5p signaling pathway[J]. Journal of Clinical Hepatology, 2021, 37(1): 147-152. doi: 10.3969/j.issn.1001-5256.2021.01.029
[7]	Xuemei DING, Shilun WU, Wenbing SUN. Value of preoperative microRNA-192 in peripheral blood mononuclear cells in predicting microvascular invasion of solitary hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(5): 1121-1125. doi: 10.3969/j.issn.1001-5256.2021.05.028
[8]	Sheng CHEN, Guoxiang CHEN, Zhongming HE, Shujie CHENG, Jisen ZHAO. Role of miRNA in the development and progression of cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2021, 37(9): 2241-2245. doi: 10.3969/j.issn.1001-5256.2021.09.048
[9]	Jianheng HAO, Zhencheng LI, Ying LIU, Yiwen HOU, Yan GAO, Yuchuan MIAO, Yang LIU, Huiqin HAO. A functional analysis of differentially expressed microRNAs involved in liver injury in mice with autoimmune hepatitis induced by concanavalin A[J]. Journal of Clinical Hepatology, 2021, 37(6): 1360-1367. doi: 10.3969/j.issn.1001-5256.2021.06.028
[10]	Xiuhong HUANG, Xiaoli XIE, Huiqing JIANG. Value of a microRNA risk score model in predicting the prognosis of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(5): 1110-1115. doi: 10.3969/j.issn.1001-5256.2021.05.026
[11]	Nannan QIAN, Lulu TANG, Taohua WEI, Yue YANG, Wenjie HAO, Wenming YANG. Role and mechanism of exosome non-coding RNA in liver fibrosis[J]. Journal of Clinical Hepatology, 2021, 37(10): 2429-2434. doi: 10.3969/j.issn.1001-5256.2021.10.036
[12]	Yan JIAO, Ying ZHANG, Honglin SHI, Wang LU, Dexi CHEN, Yu CHEN, Hongbo SHI. A bioinformatics analysis of differentially expressed proteins in plasma exosome of acute-on-chronic liver failure patients with different prognoses[J]. Journal of Clinical Hepatology, 2021, 37(4): 834-840. doi: 10.3969/j.issn.1001-5256.2021.04.022
[13]	Ye Jun, Han ShanShan, Lu XinYi, Shang YuTao, Feng ZhiQiang. microRNA-18a upregulates the regulatory immune function in patients with chronic hepatitis B through the PPARα/γ signaling pathway[J]. Journal of Clinical Hepatology, 2020, 36(5): 1024-1028. doi: 10.3969/j.issn.1001-5256.2020.05.015
[14]	Wang ZhiXin, Gou Ping, Yu WenHao, Ren Li, Yang DanCaiRang, Wang HaiJiu, Fan HaiNing. Measurement and bioinformatics analysis of exosomes microRNAs in bile of hepatic alveolar echinococcosis patients with biliary tract invasion[J]. Journal of Clinical Hepatology, 2020, 36(9): 2045-2049. doi: 10.3969/j.issn.1001-5256.2020.09.027
[15]	Zhang ShiWan, Yu XueQin, Chen Fang, Mei YiHan, Mei XiaoPing. Biological characteristics of exosome microRNA and its role in the development and progression of liver fibrosis[J]. Journal of Clinical Hepatology, 2020, 36(9): 2083-2086. doi: 10.3969/j.issn.1001-5256.2020.09.039
[16]	Wu JunYi, Lai ZhiDe, Tian YiFeng, Wang YaoDong. Expression and clinical significance of serum exosomal microRNA-221-3p in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2020, 36(8): 1768-1772. doi: 10.3969/j.issn.1001-5256.2020.08.018
[17]	Wang QingLan, Tao YanYan, Lu: Jing, Liu Ping, Liu ChengHai. Antifibrotic mechanism of Fuzheng Huayu prescription by regulation of the differential expression of microRNAs in mouse liver[J]. Journal of Clinical Hepatology, 2016, 32(3): 503-508. doi: 10.3969/j.issn.1001-5256.2016.03.022
[18]	Lin Kun, Ci DanWangJiu, Chang ZhiHui, Liu ZhaoYu. Clinical value of circulating micro RNAs in hepatic,biliary and pancreatic carcinomas[J]. Journal of Clinical Hepatology, 2015, 31(5): 790-795. doi: 10.3969/j.issn.1001-5256.2015.05.040
[19]	Li Qiang, Zhuo QiBin, Huang YuXian, Chen Liang. Diagnosis and treatment of hepatocellular carcinoma from a new perspective of miRNAs[J]. Journal of Clinical Hepatology, 2015, 31(6): 977-981. doi: 10.3969/j.issn.1001-5256.2015.06.037
[20]	Hu XueLing, Fan GongRen. Functional role of microRNAs in viral hepatitis infections[J]. Journal of Clinical Hepatology, 2012, 28(11): 877-880.

Supplements(1)

Supplements

慢性乙型肝炎与HBV相关慢加急性肝衰竭患者血浆外泌体差异miRNA的生物信息学分析.pdf

Cited By

Cited by

Periodical cited type(3)

1.	高莉萍，孙贝贝，刘晓金. 氢化可的松联合恩替卡韦对早期乙型肝炎肝衰竭免疫功能及炎性因子MCP-1、1L-1β及HMGB1的影响研究. 医药论坛杂志. 2024(07): 705-709 .
2.	林玲辉，李娜，尹晓燕，王晓凌，胡亚平，刘威，费瑞，田新利. 基于幽门螺杆菌hp0169基因三维结构的生物信息学分析. 吉林大学学报(医学版). 2024(03): 739-748 .
3.	方绕红，尚高霞，尹鹏燕，张世德，陈梅，李庆蓉. 血清甲胎蛋白、p62及LC3-Ⅱ在HBV相关慢加急性肝衰竭预后评估中的应用. 肝脏. 2023(12): 1418-1422 .

Other cited types(1)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(6) / Tables(2)

Get Citation

PDF

XML

Article Metrics

Article views (511) PDF downloads(23)

Differentially expressed microRNAs in plasma exosomes from patients with chronic hepatitis B or hepatitis B virus-related acute-on-chronic liver failure: A bioinformatics analysis

DOI: 10.3969/j.issn.1001-5256.2023.08.013